Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: ADVANCED GLYCATION END PRODUCTS, . Treffer: 10

2019

Jud, P; Sourij, H Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review.
Diabetes Res Clin Pract. 2019; 148:54-63
Web of Science PubMed FullText FullText_MUG

 

2018

Borghetti, G; von Lewinski, D; Eaton, DM; Sourij, H; Houser, SR; Wallner, M Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control.
Front Physiol. 2018; 9(11):1514-1514 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Hofmann, AD; Friedmacher, F; Takahashi, T; Gosemann, JH; Puri, P Increased pulmonary vascular expression of receptor for advanced glycation end products (RAGE) in experimental congenital diaphragmatic hernia.
J Pediatr Surg. 2015; 50(5):746-749
Web of Science PubMed FullText FullText_MUG

 

2009

Boyanova, M; Huppertz, B CYTOTOXIC EFFECT OF ADVANCED GLYCATION END PRODUCTS
BIOTECHNOL BIOTECHNOL EQUIP. 2009; 23(1): 1072-1078. [OPEN ACCESS]
Web of Science

 

Marsche, G; Frank, S; Hrzenjak, A; Holzer, M; Dirnberger, S; Wadsack, C; Scharnagl, H; Stojakovic, T; Heinemann, A; Oettl, K Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo.
Circ Res. 2009; 104(6): 750-757. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Sundl, I; Roob, JM; Meinitzer, A; Tiran, B; Khoschsorur, G; Haditsch, B; Holzer, H; Winklhofer-Roob, BM Antioxidant status of patients on peritoneal dialysis: associations with inflammation and glycoxidative stress.
Perit Dial Int. 2009; 29(1): 89-101. [OPEN ACCESS]
Web of Science PubMed FullText

 

2007

Marsche, G; Semlitsch, M; Hammer, A; Frank, S; Weigle, B; Demling, N; Schmidt, K; Windischhofer, W; Waeg, G; Sattler, W; Malle, E Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway.
FASEB J. 2007; 21(4): 1145-1152. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Marsche, G; Weigle, B; Sattler, W; Malle, E Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein.
FASEB J. 2007; 21(12): 3075-3082. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Scharnagl, H; Stojakovic, T; Winkler, K; Rosinger, S; März, W; Boehm, BO The HMG-CoA reductase inhibitor cerivastatin lowers advanced glycation end products in patients with type 2 diabetes.
EXP CLIN ENDOCRINOL DIABETES. 2007; 115(6): 372-375.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Malle, E; Buch, T; Grone, HJ Myeloperoxidase in kidney disease.
Kidney Int. 2003; 64(6):1956-1967 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

© Meduni Graz Impressum